- Home
- BHAT vs SNSE Comparison
BHAT vs SNSE Comparison
Compare BHAT & SNSE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BHAT
- SNSE
- Stock Information
- Founded
- BHAT 2010
- SNSE 2005
- Country
- BHAT China
- SNSE United States
- Employees
- BHAT N/A
- SNSE N/A
- Industry
- BHAT Recreational Games/Products/Toys
- SNSE Biotechnology: Pharmaceutical Preparations
- Sector
- BHAT Consumer Discretionary
- SNSE Health Care
- Exchange
- BHAT Nasdaq
- SNSE Nasdaq
- Market Cap
- BHAT 12.7M
- SNSE 10.2M
- IPO Year
- BHAT 2019
- SNSE 2021
- Fundamental
- Price
- BHAT $1.65
- SNSE $8.81
- Analyst Decision
- BHAT
- SNSE Strong Buy
- Analyst Count
- BHAT 0
- SNSE 4
- Target Price
- BHAT N/A
- SNSE $72.50
- AVG Volume (30 Days)
- BHAT 109.5K
- SNSE 16.3K
- Earning Date
- BHAT 04-30-2025
- SNSE 08-05-2025
- Dividend Yield
- BHAT N/A
- SNSE N/A
- EPS Growth
- BHAT N/A
- SNSE N/A
- EPS
- BHAT N/A
- SNSE N/A
- Revenue
- BHAT $18,724,190.00
- SNSE N/A
- Revenue This Year
- BHAT N/A
- SNSE N/A
- Revenue Next Year
- BHAT N/A
- SNSE N/A
- P/E Ratio
- BHAT N/A
- SNSE N/A
- Revenue Growth
- BHAT N/A
- SNSE N/A
- 52 Week Low
- BHAT $1.51
- SNSE $5.00
- 52 Week High
- BHAT $47.14
- SNSE $17.40
- Technical
- Relative Strength Index (RSI)
- BHAT 46.63
- SNSE 56.87
- Support Level
- BHAT $1.60
- SNSE $7.79
- Resistance Level
- BHAT $1.92
- SNSE $8.69
- Average True Range (ATR)
- BHAT 0.12
- SNSE 0.70
- MACD
- BHAT 0.01
- SNSE 0.06
- Stochastic Oscillator
- BHAT 34.15
- SNSE 73.06
About BHAT Blue Hat Interactive Entertainment Technology
Blue Hat Interactive Entertainment Technology is focused on commodity trading, including chemicals, jewelry, and precious metals such as gold. It operates a gold and diamond trading and supply chain business. Its business model encompasses physical gold trading, diamond trading, gold derivatives trading, and the development of AI-enabled trading platforms. Its segments include Diamond trading, Commodity trading, Information service, Interactive toys - animation series, and Interactive toys - game series. It derives revenue from Diamond trading. The majority of its revenues are generated in PRC.
About SNSE Sensei Biotherapeutics Inc.
Sensei Biotherapeutics Inc is an immuno-oncology company focused on the discovery and development of next-generation therapeutics for cancer patients. Its TMAb (Tumor Microenvironment Activated Biologics) platform developing selective therapeutics designed to disable immunosuppressive signals or activate immunostimulatory signals selectively in the tumor microenvironment. The company have four investigational product candidates in various stages of development: SNS-101 (VISTA), SNS-102 (VSIG4 ), SNS-103 (ENTPDase/CD39), SNS-201 (VISTAxCD28).